Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Agoston
Attila Agoston, Wien AT
| Patent application number | Description | Published |
|---|---|---|
| 20090074613 | APPARATUS FOR DISTINGUISHING BETWEEN AIRCRAFT CONSUMABLES | 03-19-2009 |
Gregory E. Agoston, Rockville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090029992 | SUBSTITUTED PYRAZOLE COMPOUNDS - Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer. | 01-29-2009 |
| 20090264422 | METHOD OF TREATING DISEASE STATES USING SUBSTITUTED PYRAZOLE COMPOUNDS - Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer. | 10-22-2009 |
Gregory E. Agoston, Germantown, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090105205 | METHODS OF TREATING DISEASE STATES USING ANTIANGIOGENIC AGENTS - Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: | 04-23-2009 |
Karoly Agoston, Szekesfehrvar HU
| Patent application number | Description | Published |
|---|---|---|
| 20110060139 | CARBOHYDRATE DERIVATIVES - A 1,2-dideoxy-1,2-diamino oligosaccharide or polysaccharide in its free base, salt or metal-complex form as shown in General Formula 1 and derivative thereof is described. | 03-10-2011 |
Karoly Agoston, Szekesfehervar HU
| Patent application number | Description | Published |
|---|---|---|
| 20100261873 | GLYCOPROTEINS AND GLYCOSYLATED CELLS AND A METHOD FOR THE PREPARATION OF THE SAME - The present application discloses novel glycoproteins and a related glycosylcarbamoylation methodology suitable for the preparation of glycopeptides (in particular glycoproteins and glycosylated cells), as well as the use of such glycoproteins in medicine, e.g. as pharmaceuticals and diagnostics or in diagnostic kits. The method for the preparation of a carbohydrate-peptide conjugate comprises reacting a cyclic carbamate (1) (wherein R | 10-14-2010 |
| 20110166339 | CRYSTALLINE CARBOHYDRATE DERIVATIVE - α-Lactosamine hydrochloride, substantially free of β-lactosamine hydrochloride; a method of preparing α-lactosamine hydrochloride monohydrate from an anomeric mixture of lactosamine hydrochloride, including: preparing a solution including the anomeric mixture of lactosamine hydrochloride, water and at least one water-miscible organic solvent at a temperature of 0-100° C., and cooling the solution to cause crystallisation of α-lactosamine hydrochloride monohydrate; a method of preparing anhydrous α-lactosamine hydrochloride; and use of α-lactosamine hydrochloride as a food supplement or intermediate in synthesis. | 07-07-2011 |
Maria Agoston, Beaverton, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20090074030 | Method of Characterizing Parameters and Removing Spectral Components of a Spread Spectrum Clock in a Communications Signal - Parameters of a spread spectrum clock signal in a communication signal are characterized by acquiring voltage samples of the communication signal at a nominal time location of an edge of the communication signal. The voltage samples are converted to time samples and the difference between the maximum and minimum time values is determined at the nominal time location. A spread spectrum clock magnitude number is generated by dividing the difference between the maximum and minimum time values by the nominal time location of the acquired voltage samples of the spread spectrum clock signal. A spread spectrum modulation profile of a spread spectrum clock signal is estimated by over sampling the time samples using an aliased index value to generate over sampled triangular waveforms representing the spread spectrum clock modulation profile. One of the over sampled triangular waveforms is use to generate the spread spectrum clock modulation profile. | 03-19-2009 |
| 20110103451 | System for Independently Modifying Jitter and Noise Components in a Signal Measurement Device - A digitizing instrument is used for modifying pattern data and jitter and noise components of a communication signal. In a typical implementation, the midpoints of a rising edge slope and horizontal portion of the communication signal are determined and multiple digital data records are acquired at the midpoints. The data sample records are transformed to frequency components and the random jitter and noise, and periodic jitter and noise components are determined. A correlated pattern data and the jitter and noise components are matrix elements in a simulated signal channel having communication system elements. Each correlated pattern data and jitter and noise component may be modified for each of the communication system element. The selectively modified correlated pattern data and jitter and noise components are combined to produce a modified communication signal that is displayed as a numeric table, eye diagram or bit error rate presentation. | 05-05-2011 |
Márta Agoston, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090233913 | OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS - The present invention relates to dihydro-2,3-benzodiazepine compounds of high enantiomeric purity according to the general formula (I), which contain an asymmetric centre at the position 4 of the dihydro-2,3-benzodiazepine compound, and the preparation thereof and the used intermediates as well. These compounds have anti-convulsiveA muscle relaxant and neuroprotective effect due their non-competitive AMPA antagonistic properties. | 09-17-2009 |
| 20100075975 | MEDICAMENT FOR THE ENHANCEMENT OF COGNITIVE FUNCTION AND NEUROPROTECTION - The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H) pyridazinone of the Formula (I) | 03-25-2010 |